Compound Dihuang Granule Inhibits Nigrostriatal Pathway Apoptosis in Parkinson's Disease by Suppressing the JNK/AP-1 Pathway

• Egile Nagusiak: Li Wang (Egilea), Yu-fang Yang (Egilea), Long Chen (Egilea), Zhu-qing He (Egilea), Dian-yong Bi (Egilea), Lei Zhang (Egilea), Yan-wu Xu (Egilea), Jian-cheng He (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Compound Dihuang Granule (CDG) is widely used in traditional Chinese medicine (TCM) for the treatment of Parkinson's disease (PD). It has been shown to alleviate PD symptoms. However, the molecular mechanisms of its action have not been established. To establish the molecular mechanisms of CDG...